Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Early Phase 1
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Early Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06424366Not ApplicableCompleted

Approach to Dance for Autism

Role: collaborator

NCT05865067Not ApplicableUnknown

Yoga Therapy and Oppositional Defiant Disorder Behaviors

Role: collaborator

NCT02037035Early Phase 1Completed

Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling

Role: collaborator

NCT00391261Phase 4Completed

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

Role: collaborator

All 4 trials loaded